David Fitzpatrick

917 total citations
23 papers, 494 citations indexed

About

David Fitzpatrick is a scholar working on Epidemiology, Nephrology and Surgery. According to data from OpenAlex, David Fitzpatrick has authored 23 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in Nephrology and 4 papers in Surgery. Recurrent topics in David Fitzpatrick's work include Gout, Hyperuricemia, Uric Acid (5 papers), Pneumonia and Respiratory Infections (4 papers) and Respiratory viral infections research (3 papers). David Fitzpatrick is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (5 papers), Pneumonia and Respiratory Infections (4 papers) and Respiratory viral infections research (3 papers). David Fitzpatrick collaborates with scholars based in United States, United Kingdom and New Zealand. David Fitzpatrick's co-authors include Scott Baumgartner, Michael A. Becker, Chris Storgard, Maple M. Fung, Kenneth G. Saag, Nihar Bhakta, Jeff Kopicko, Scott Adler, Matt Cravets and David J. French and has published in prestigious journals such as New England Journal of Medicine, JAMA and Current Biology.

In The Last Decade

David Fitzpatrick

22 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Fitzpatrick United States 11 272 207 113 70 54 23 494
O Leri Italy 11 25 0.1× 124 0.6× 83 0.7× 115 1.6× 38 0.7× 26 508
Selma A. Palácios Brazil 16 21 0.1× 96 0.5× 121 1.1× 306 4.4× 94 1.7× 19 603
Issam Mansour Lebanon 12 33 0.1× 52 0.3× 50 0.4× 55 0.8× 162 3.0× 35 612
P Vinceneux France 11 31 0.1× 157 0.8× 72 0.6× 160 2.3× 39 0.7× 62 444
Erika Kuwahara Japan 7 18 0.1× 50 0.2× 15 0.1× 54 0.8× 14 0.3× 9 359
K Berglund Sweden 14 14 0.1× 36 0.2× 75 0.7× 62 0.9× 108 2.0× 35 497
Masatsugu Ohtsuki Japan 11 8 0.0× 101 0.5× 55 0.5× 39 0.6× 61 1.1× 31 436
Smith United Kingdom 11 7 0.0× 48 0.2× 63 0.6× 34 0.5× 40 0.7× 38 373
J. L. Kalliomäki Finland 13 14 0.1× 69 0.3× 168 1.5× 99 1.4× 34 0.6× 63 503
Hong He China 12 39 0.1× 41 0.2× 3 0.0× 114 1.6× 63 1.2× 36 434

Countries citing papers authored by David Fitzpatrick

Since Specialization
Citations

This map shows the geographic impact of David Fitzpatrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Fitzpatrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Fitzpatrick more than expected).

Fields of papers citing papers by David Fitzpatrick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Fitzpatrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Fitzpatrick. The network helps show where David Fitzpatrick may publish in the future.

Co-authorship network of co-authors of David Fitzpatrick

This figure shows the co-authorship network connecting the top 25 collaborators of David Fitzpatrick. A scholar is included among the top collaborators of David Fitzpatrick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Fitzpatrick. David Fitzpatrick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wallace, Damian J., Kay-Michael Voit, J Sawiński, et al.. (2025). Eye saccades align optic flow with retinal specializations during object pursuit in freely moving ferrets. Current Biology. 35(4). 761–775.e10. 1 indexed citations
2.
Fitzpatrick, David, Lisa A. Jackson, Graham Crowther, et al.. (2025). Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine. New England Journal of Medicine. 393(20). 2001–2011. 3 indexed citations
3.
Fitzpatrick, David, Anthony Mills, Archana Kapoor, et al.. (2024). Safety and immunogenicity of an mRNA-based RSV vaccine in Japanese older adults aged ≥60 years: A phase 1, randomized, observer-blind, placebo-controlled trial. Respiratory Investigation. 62(6). 1037–1043. 6 indexed citations
6.
Peterson, James T., Agnieszka Zareba, David Fitzpatrick, et al.. (2021). Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F Vaccine When Coadministered With a Tetanus, Diphtheria, and Acellular Pertussis Vaccine. The Journal of Infectious Diseases. 225(12). 2077–2086. 31 indexed citations
7.
Fitzpatrick, David, Daniel A. Scott, Ingrid L. Scully, et al.. (2021). A randomized phase 1 study of the safety and immunogenicity of 2 novel pneumococcal conjugate vaccines in healthy Japanese adults in the United States. Human Vaccines & Immunotherapeutics. 17(7). 2249–2256. 9 indexed citations
8.
Gibney, Michael A., et al.. (2020). User experiences with second-generation 32-gauge × 4 mm vs. thinner comparator pen needles: prospective randomized trial. Current Medical Research and Opinion. 36(10). 1591–1600. 6 indexed citations
9.
Su, Yan, et al.. (2017). Safety and long-term immunological effects of CryJ2-LAMP plasmid vaccine in Japanese red cedar atopic subjects: A phase I study. Human Vaccines & Immunotherapeutics. 13(12). 2804–2813. 46 indexed citations
10.
Saag, Kenneth G., David Fitzpatrick, Jeff Kopicko, et al.. (2016). Lesinurad Combined With Allopurinol: A Randomized, Double‐Blind, Placebo‐Controlled Study in Gout Patients With an Inadequate Response to Standard‐of‐Care Allopurinol (a US‐Based Study). Arthritis & Rheumatology. 69(1). 203–212. 135 indexed citations
11.
Becker, Michael A., David Fitzpatrick, Hyon K. Choi, et al.. (2015). An open-label, 6-month study of allopurinol safety in gout: The LASSO study. Seminars in Arthritis and Rheumatism. 45(2). 174–183. 90 indexed citations
12.
Mackler, Bruce, et al.. (2014). Poster 2011: A DNA vaccine immunotherapy for japanese red cedar allergy. World Allergy Organization Journal. 7. P23–P23. 3 indexed citations
13.
Becker, Michael A., Alan S. Hollister, Robert Terkeltaub, et al.. (2012). FRI0367 BCX4208 added to allopurinol increases response rates in patients with GOUT who fail to reach goal range serum uric acid on allopurinol alone: A randomized, double-blind, placebo-controlled trial. Annals of the Rheumatic Diseases. 71. 438–438. 7 indexed citations
14.
Augustine, George J, David Fitzpatrick, Lawrence C Katz, et al.. (2001). Physiological Changes Associated with Emotion. 3 indexed citations
15.
Purves, Dale, George J Augustine, David Fitzpatrick, et al.. (2001). The Development of Language: A Critical Period in Humans. 11 indexed citations
16.
Purves, Dale, George J Augustine, David Fitzpatrick, et al.. (2001). The Refractory Period. 2 indexed citations
17.
Purves, Dale, George J Augustine, David Fitzpatrick, et al.. (2001). Functional Specialization of the Rod and Cone Systems. 7 indexed citations
18.
Fitzpatrick, David. (1980). Pituitary apoplexy. The importance of skull roentgenograms and computerized tomography in diagnosis. JAMA. 244(1). 59–61. 20 indexed citations
19.
French, David J., et al.. (1972). Operant investigation of mating preference in female rats.. Journal of Comparative and Physiological Psychology. 81(2). 226–232. 36 indexed citations
20.
Janower, Murray L., et al.. (1968). Late Clinical and Laboratory Manifestations of Thorotrast Administration in Cerebral Arteriography. New England Journal of Medicine. 279(4). 186–189. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026